Genocea Biosciences Inc (OTCPK:GGNNQ)
$ 0.0005 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2018 Genocea Biosciences Inc Earnings Call Transcript

Feb 28, 2019 / 02:00PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Genocea Biosciences Fourth Quarter 2018 Financial Results Conference Call. (Operator Instructions) As a reminder, today's conference may be recorded.

I would now like to turn the call over to Paul Arndt, Managing Director, LifeSci Advisors. Sir, please begin.

Paul J. Arndt
LifeSci Advisors, LLC - Head of IR and MD, Communications

Thank you, Mark, and good morning, everyone. This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available at genocea.com, under the Investor Relations tab.

During the call today, Chip Clark, President and Chief Executive officer, will provide a corporate update and review the financial results. After his prepared remarks, we will open up the call to Q&A, and Chip; Jessica Flechtner, Genocea's Chief Scientific Officer; and Tom Davis, Genocea's Chief Medical Officer, will then be available to answer your questions.

Before we begin, I would like to remind everyone that statements made during this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot